Nemera News

Nemera News

  • NEMERA will be SPEAKER and EXHIBITOR at CphI Worldwide (Madrid)

    October 7, 2015

    Nemera will join 36,000 senior pharma professionals at CPhI Worldwide, which will take place in Madrid from 13th to 15th October 2015. Visit booth 4C40 and discover how innovating for patients is at the core of Nemera’s mission! Don’t miss our speeches on the Exhibition showcase (Hall 4): on Tuesday 13th October at 3 pm discover Nemera and Rommelag presenting the

    Read more
  • Nemera’s next generation nasal spray, Advancia®, is now in production with 45 million units’ annual capacity

    September 17, 2015

    Nemera has invested more than 10 million euros in R&D and manufacturing to launch the only user-independent multi-dose nasal spray system on the market. So far, the drug product packaging for Advancia® is approved in one European country. Advancia® represents a major breakthrough in nasal drug delivery by providing patients with a user-independent system ideal for topical and systemic preserved

    Read more
  • Seen in the press : Intelligent ophthalmic drug delivery on PMPS (Issue No. 68)

    August 26, 2015

    The August issue of PMPS (Pharmaceutical Manufacturing and Packing Sourcer) magazine talks about an innovative design that enables the production of preservative-free multidose eyedroppers, as Novelia®. The article, written for Nemera by a scientific writer, explains how this design can provide an easy way to deliver safe, cost-effective and preservative-free treatment. You can download the article here. You can read

    Read more
  • Nemera will be sponsor and speaker at the 5th annual Partnership Opportunities in Drug Delivery conference – PODD, Boston, USA

    July 17, 2015

    Nemera will join the 5th Annual PODD in Boston, Partnership Opportunities in Drug Delivery, which will take place on 5-6 October 2015 in Boston. The ultimate goal for PODD is to foster a meeting place that inspires innovation and advancement of drug development and delivery as well as providing support for the leaders behind the movement.

    Read more
  • A ‘Double First’ for Novelia®!

    June 18, 2015

    Novelia®, our preservative-free multidose eyedropper, has been commercialized for the first time for anti-glaucoma products!
    AND for the first time it has been launched on the Indian market!

    Novelia®, for delivering safe, multidose preservative-free eye drops.

    Read more